Membrane Permeability Drives the Extreme Potency of Fentanyl

膜通透性是芬太尼极强效力的驱动因素。

阅读:2

Abstract

Fentanyl is a leading cause of drug overdose deaths in the United States, yet the mechanism driving its extreme in vivo potency is poorly defined. Here we developed novel computational and experimental approaches to examine whether the membrane contributes to the in vivo potency of fentanyl. Using weighted-ensemble continuous constant pH molecular dynamics (WE-CpHMD) simulations, we estimated the permeability of ionized fentanyl to be approximately 10(-7) cm/s, about 100-fold higher than that of ionized morphine and several more orders of magnitude higher than those of ionized naloxone and isotonitazene. Simulations revealed that all opioids deprotonate when diffusing below the lipid headgroup region, with isotonitazene and naloxone deprotonating closer to the hydrophobic core. Mean first passage time calculation revealed fentanyl's rapid kinetics for bidirectional membrane transport, suggesting that it partitions into and permeates the membrane while also redistributing back into solution from both the membrane core and intracellular compartment. Consistently, cell washout experiments making use of a BRET senor demonstrated that fentanyl, but not morphine, is retained by cells and can repartition into solution to reactivate the mu-opioid receptor. The IAM-HPLC measurement confirmed fentanyl's superior phospholipophilicity. These findings support the hypothesis that membrane permeation is a major driver of fentanyl's extreme analgesic potency, rapid onset, and short duration of action, revealing a fundamental mechanism underlying opioid toxicity, with implication for developing more effective countermeasures. WE-CpHMD provides a valuable tool for mechanistic elucidation of membrane permeation of ionizable molecules, which remains poorly understood.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。